{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:06:11Z","timestamp":1787313971937,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cllc.2018.04.019","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T21:38:55Z","timestamp":1525469935000},"page":"e685-e692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States"],"prefix":"10.1016","volume":"19","author":[{"given":"Sherif G.","family":"Shaaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5863-6023","authenticated-orcid":false,"given":"Vivek","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Isabelle","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1880-1207","authenticated-orcid":false,"given":"Jacob","family":"Shabason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonam","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahed N.","family":"Badiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2018.04.019_bib1","author":"National Comprehensive Cancer Network"},{"key":"10.1016\/j.cllc.2018.04.019_bib2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.athoracsur.2007.04.076","article-title":"Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"84","author":"Rice","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2018.04.019_bib6","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","article-title":"Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"83","author":"Rosenzweig","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/JTO.0b013e31827740f0","article-title":"Patterns of failure, toxicity, and survival after extrapleural pneumonectomy and hemithoracic intensity-modulated radiation therapy for malignant pleural mesothelioma","volume":"8","author":"Gomez","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","article-title":"Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy","volume":"10","author":"Thieke","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","article-title":"Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis","volume":"91","author":"Chance","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib10","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1245\/s10434-007-9747-3","article-title":"The National Cancer Data Base: a powerful initiative to improve cancer care in the United States","volume":"15","author":"Bilimoria","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib12","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jtho.2017.08.012","article-title":"National Cancer Database report on pneumonectomy versus lung-sparing surgery for malignant pleural mesothelioma","volume":"12","author":"Verma","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"suppl 5","key":"10.1016\/j.cllc.2018.04.019_bib13","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdq173","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Stahel","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ijrobp.2011.11.057","article-title":"Effect of increasing experience on dosimetric and clinical outcomes in the management of malignant pleural mesothelioma with intensity-modulated radiation therapy","volume":"83","author":"Patel","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib15","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib16","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijrobp.2007.03.011","article-title":"Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma","volume":"69","author":"Rice","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib17","doi-asserted-by":"crossref","first-page":"E120","DOI":"10.3390\/cancers9090120","article-title":"Acute and late toxicities of concurrent chemoradiotherapy for locally-advanced non\u2013small-cell lung cancer","volume":"9","author":"Verma","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cllc.2018.04.019_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.athoracsur.2016.08.071","article-title":"Extended pleurectomy-decortication-based treatment for advanced stage epithelial mesothelioma yielding a median survival of nearly three years","volume":"103","author":"Friedberg","year":"2017","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.cllc.2018.04.019_bib19","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/S1470-2045(16)00024-3","article-title":"Hemithoracic radiotherapy for mesothelioma: lack of benefit or lack of statistical power?","volume":"17","author":"Rimner","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib20","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/JTO.0000000000000078","article-title":"A\u00a0feasibility study evaluating surgery for mesothelioma after radiation therapy: the \u201cSMART\u201d approach for resectable malignant pleural mesothelioma","volume":"9","author":"Cho","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cllc.2014.12.001","article-title":"Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study","volume":"16","author":"Kesarwala","year":"2015","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.cllc.2018.04.019_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A\u00a0systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2018.04.019_bib24","first-page":"E91","article-title":"Advances in radiotherapy management of esophageal cancer","volume":"5","author":"Verma","year":"2016","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.cllc.2018.04.019_bib25","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ijrobp.2015.11.043","article-title":"Improving outcomes for esophageal cancer using proton beam therapy","volume":"95","author":"Chuong","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2017.04.013","article-title":"Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer","volume":"123","author":"Lin","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib27","doi-asserted-by":"crossref","first-page":"e172032","DOI":"10.1001\/jamaoncol.2017.2032","article-title":"Proton beam radiotherapy and concurrent chemotherapy for unresectable stage III non\u2013small-cell lung cancer: final results of a phase 2 study","volume":"3","author":"Chang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2017.08.005","article-title":"Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation","volume":"125","author":"Verma","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib29","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1002\/cncr.30870","article-title":"Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer","volume":"123","author":"Rwigema","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2018.04.019_bib30","doi-asserted-by":"crossref","first-page":"djx208","DOI":"10.1093\/jnci\/djx208","article-title":"Quality of life and patient-reported outcomes following proton radiation therapy: a systematic review","volume":"110","author":"Verma","year":"2018","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2018.04.019_bib31","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ijrobp.2009.11.006","article-title":"Proton therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy","volume":"78","author":"Krayenbuehl","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.cllc.2018.04.019_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00066-011-0038-3","article-title":"Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment","volume":"188","author":"Lorentini","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.cllc.2018.04.019_bib33","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.prro.2014.11.005","article-title":"Early experience with intensity modulated proton therapy for lung-intact mesothelioma: a case series","volume":"5","author":"Pan","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.cllc.2018.04.019_bib34","first-page":"e1705","article-title":"Proton therapy for malignant pleural mesothelioma: a three case series describing the clinical and dosimetric advantages of proton-based therapy","volume":"9","author":"Lee","year":"2017","journal-title":"Cureus"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418301013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730418301013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:08:02Z","timestamp":1761505682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730418301013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1525730418301013"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2018.04.019","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2018.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}